* initial need for hospitalization for covid-19 management * pregnancy and breastfeeding * participation to another interventional drug trial * subject protected by law under guardianship or curatorship * absence of health insurance * known hypersensitivity to camostat mesylate * known person sharing the same household already included in the study * participation to another covid-19 ambulatory interventional study * patients having completed a full sars-cov2 vaccine immunization procedure less than 4 weeks prior to covid-19 diagnosis (last vaccine injection performed less than 4 weeks prior to covid-19 diagnosis)

* initial need for hospitalization for covid-19 management * pregnancy and breastfeeding * participation to another interventional drug trial * subject protected by law under guardianship or curatorship * absence of health insurance * known hypersensitivity to camostat mesylate * known person sharing the same household already included in the study * participation to another covid-19 ambulatory interventional study * patients having completed a full sars-cov2 vaccine immunization procedure less than 4 weeks prior to covid-19 diagnosis (last vaccine injection performed less than 4 weeks prior to covid-19 diagnosis)

- initial need for hospitalization for covid-19 management - pregnancy and breastfeeding - participation to another interventional drug trial - subject protected by law under guardianship or curatorship - absence of health insurance - known hypersensitivity to camostat mesylate - known person sharing the same household already included in the study - participation to another covid-19 ambulatory interventional study - patients having completed a full sars-cov2 vaccine immunization procedure less than 4 weeks prior to covid-19 diagnosis (last vaccine injection performed less than 4 weeks prior to covid-19 diagnosis)

- initial need for hospitalization for covid-19 management - pregnancy and breastfeeding - participation to another interventional drug trial - subject protected by law under guardianship or curatorship - absence of health insurance - known hypersensitivity to camostat mesylate - known person sharing the same household already included in the study - participation to another covid-19 ambulatory interventional study - patients having completed a full sars-cov2 vaccine immunization procedure less than 4 weeks prior to covid-19 diagnosis (last vaccine injection performed less than 4 weeks prior to covid-19 diagnosis)

- initial need for hospitalization for covid-19 management - pregnancy and breastfeeding - participation to another interventional drug trial - subject protected by law under guardianship or curatorship - absence of health insurance - known hypersensitivity to camostat mesylate - known person sharing the same household already included in the study - participation to another covid-19 ambulatory interventional study

- initial need for hospitalization for covid-19 management - pregnancy and breastfeeding - participation to another interventional drug trial - subject protected by law under guardianship or curatorship - absence of health insurance - known hypersensitivity to camostat mesylate - known person sharing the same household already included in the study - participation to another covid-19 ambulatory interventional study